Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
On April 19, 2021 - The FDA approved Novartis’ Diovan (valsartan), for the treatment of hypertension, to lower blood pressure in adults and pediatric patients one year of age and older.
Return to publications